Skip to the page

Data / Drug companies / Leading Pharma, LLC

Leading Pharma, LLC: 85 products in the FDA NDC directory, labeler code 69315

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Leading Pharma, LLC (labeler code 69315) lists 85 products in the FDA National Drug Code Directory, covering 41 finished drugs by generic name. By type: 85 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 20, 2026.

The request: Watch Leading Pharma, LLC (FDA labeler code 69315): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
69315
Products in commercial distribution
85
Packages
149
Finished drugs by generic name
41
Prescription products
85
Over the counter products
0
Controlled substance products
Schedule III 2, Schedule IV 6, Schedule V 2
Flagged as original packager
78 of 78 products that carry the flag
Started marketing in the last 12 months
5
Earliest marketing start
February 1, 2006
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)8195.3%
Authorized generics (NDA)22.4%
Other unapproved drugs22.4%

Products by type

TypeProductsShare
Prescription drugs85100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet3136.5%
Capsule1315.3%
Tablet, film coated1112.9%
Solution1112.9%
Solution/ drops44.7%
Tablet, extended release33.5%
Capsule, delayed release22.4%
Suspension22.4%
Ointment11.2%
Powder, for solution11.2%
Injection, powder, lyophilized, for solution11.2%
Kit11.2%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Pilocarpine hydrochloride69315-316Solution/ dropsGeneric drugs (ANDA)October 20, 2026
Pilocarpine hydrochloride69315-315Solution/ dropsGeneric drugs (ANDA)October 20, 2026
Pilocarpine hydrochloride69315-314Solution/ dropsGeneric drugs (ANDA)October 20, 2026
Frovatriptan succinate69315-157Tablet, film coatedGeneric drugs (ANDA)February 28, 2026
Ethacrynate sodium69315-701Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)January 9, 2026
Gatifloxacin69315-331SolutionGeneric drugs (ANDA)October 6, 2025
Carbinoxamine maleate69315-239TabletGeneric drugs (ANDA)August 1, 2025
Oxazepam69315-913CapsuleGeneric drugs (ANDA)July 9, 2025
Oxazepam69315-912CapsuleGeneric drugs (ANDA)July 9, 2025
Oxazepam69315-911CapsuleGeneric drugs (ANDA)July 9, 2025
Prochlorperazine maleate69315-266Tablet, film coatedGeneric drugs (ANDA)June 25, 2025
Prochlorperazine maleate69315-265Tablet, film coatedGeneric drugs (ANDA)June 25, 2025
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution69315-330SolutionGeneric drugs (ANDA)May 29, 2025
Metformin hydrochloride er69315-410Tablet, extended releaseGeneric drugs (ANDA)May 1, 2025
Difluprednate69315-329EmulsionGeneric drugs (ANDA)February 18, 2025
Timolol maleate69315-325SolutionGeneric drugs (ANDA)November 7, 2024
Phenylephrine hydrochloride69315-324SolutionGeneric drugs (ANDA)September 5, 2024
Phenylephrine hydrochloride69315-323SolutionGeneric drugs (ANDA)September 5, 2024
Allopurinol69315-409TabletGeneric drugs (ANDA)September 1, 2024
Ofloxacin69315-327SolutionGeneric drugs (ANDA)July 15, 2024
Ketorolac Tromethamine69315-322Solution/ dropsGeneric drugs (ANDA)June 1, 2024
Allopurinol69315-292TabletGeneric drugs (ANDA)May 1, 2024
Allopurinol69315-291TabletGeneric drugs (ANDA)May 1, 2024
Ofloxacin69315-320SolutionGeneric drugs (ANDA)March 1, 2024
Ketorolac tromethamine69315-260Tablet, film coatedGeneric drugs (ANDA)March 1, 2024

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.